The Food and Drug Administration has released a new artificial intelligence X-ray device that shortens the time it takes to diagnose and treat a collapsed lung from eight hours to just 15 minutes, according to GE Healthcare, the company said Thursday.
The device, called Critical Care Suite, uses AI algorithms to scan X-ray images and detect pneumothorax. This deadly condition is commonly referred to as a collapsed lung and affects approximately 74,000 Americans annually.
"The healthcare industry is producing huge amounts of data from images to digital health records," said Kieran Murphy, CEO of GE Healthcare, in an interview with CNBC before the announcement. "We strongly believe that you need to transform that data into information and insight to improve results."
GE Healthcare, a leading provider of hospital and laboratory equipment, said its goal was to integrate AI into all aspects of healthcare. A system to improve patient outcomes, reduce waste and inefficiencies, and eliminate costly mistakes.
General Electric's technology, developed in collaboration with a scientist at the University of California, San Francisco, is used to detect pneumothorax. It is working to improve it to detect other health conditions.
The technology uses AI to analyze X-ray images, the company said. If a condition is suspected ̵
"Currently, 62% of portable breast exams are labeled 'STAT' or for urgent reading, but they're not all critical." Jie Xue, president and CEO of the company's X-ray department, said, "This will delay the turnaround on truly critical patients, which can be a serious problem." This reduces costs and inefficiencies. While there is optimism, there are also concerns that technology makes important medical decisions.
"There is no indication that you are replacing the radiologist," Murphy said in an interview. "Of course, [the radiologist] will consider whether they agree with the conclusion. So far, the accuracy of a large pneuomothroax is 96% and a very small number of false ones and is of course also a problem. "
The device is expected to be available in the US market this year.
The health unit is It has grown dramatically since it began developing X-rays in 1896. The company has grown to become a leader in healthcare, and is already a leading provider of hospital and laboratory equipment and a growing force in the field Medical Records and Healthcare Software In February, GE announced it was selling its biopharmaceutical stake to an industrial company Danaher for $ 21.4 billion.